Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026

Go back to Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026
(NASDAQ: CRNX) Delayed: 84.95 --0 (-0%)
Previous Close $84.95    52 Week High
Open $84.95    52 Week Low
Day High $84.95    P/E N/A 
Day Low $84.95    EPS
Volume 581